EATG, News WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance November 18, 2016 1628
Facebook Twitter Google+ Post Views: 1,628 TBTreatmentWHO Share the News Facebook Twitter VKontakte Google+ European Antibiotic Awareness Day 2016 Genetically engineered T cells render HIV’s harpoon powerless Related News 2045 Behavioral intervention reduces HIV transmission risk in young transgender women 2534 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 2517 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 2358 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2891 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
2534 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
